A Covalently Stabilized Lipid-Polycation-DNA (sLPD) Vector for Antisense Oligonucleotide Delivery

作者：Yang Xiaojuan; Peng Yong; Yu Bo; Yu Jianhua; Zhou Chenguang; Mao Yicheng; Lee L James; Lee Robert J^*

来源：Molecular Pharmaceutics, 2011, 8(3): 709-715.

DOI：10.1021/mp100272k

• nanoparticles
• antisense oligonucleotide
• reversible cross-linking
• cancer
• immunotherapy
• drug delivery

Antisense oligonucleotide G3139 is designed for Bcl-2 downregulation and is known to induce toll-like receptor activation. Novel stabilized lipid-polycation-DNA (sLPD) nanoparticles were constructed and evaluated for the delivery of G3139 to human carcinoma KB cells and for bioactivity in vivo. Polyethylenimine (PEI) was incorporated as a DNA condensing agent. The lipid composition used was DOTAP/DDAB/Chol/TPGS/linoleic acid/hexadecenal at molar ratios of 30/30/34/1/5/0.2. The nanoparticles were stabilized by the formation of a reversible covalent bond between the aldehyde group on the cis-11-hexadecenal and amines on the PEI. When sLPDs were used to transfect KB cells, 90.4% Bcl-2 downregulation was observed, compared to no significant downregulation by free G3139 and 54.6% downregulation by nonstabilized LPD-G3139. The sLPDs were then evaluated for therapeutic efficacy in mice bearing KB subcutaneous tumors and were found to trigger a strong antitumor response, inhibiting tumor growth and prolonging survival with 72% increase in lifespan (LLS). Consistent with previous reports on other G3139 nanoparticles, the increased antitumor activities of sLPDs in vivo were found to be associated with increased cytokine induction rather than Bcl-2 downregulation, suggesting an immunological mechanism.

• 出版日期2011-6